Johnson & Johnson traded at $176.99 this Wednesday June 29th, increasing $0.05 or 0.03 percent since the previous trading session. Looking back, over the last four weeks, J&J gained 1.41 percent. Over the last 12 months, its price rose by 7.44 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 177.39 by the end of this quarter and at 163.45 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
176.99
Daily Change
0.03%
Yearly
7.44%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 154.14 1.65 1.08% 36.84%
Abiomed 256.49 7.41 2.97% -17.82%
Abbott 109.10 2.13 1.99% -5.89%
Amgen 245.43 1.92 0.79% 0.69%
AstraZeneca 11,054.00 268.00 2.48% 27.31%
Astrazeneca 67.02 1.09 1.65% 11.89%
Baxter International 65.81 0.56 0.86% -18.25%
Bayer 57.62 -2.61 -4.33% 12.52%
Becton, Dickinson and Co. 249.34 4.81 1.97% 2.53%
Biogen 205.23 2.72 1.34% -40.73%
Bristol-Myers Squibb 78.28 -0.42 -0.53% 17.15%
Boston Scientific 37.80 0.30 0.80% -11.60%
CONMED 100.00 2.51 2.57% -27.24%
Cooper Companies 317.71 3.63 1.16% -19.82%
Cardiovascular Systems 14.65 0.03 0.21% -65.65%
Dexcom 75.45 0.75 1.00% -82.33%
Edwards Lifesciences 96.03 1.30 1.37% -7.28%
Gilead Sciences 62.48 0.27 0.43% -9.27%
Globus Medical 57.53 -0.02 -0.03% -25.80%
GlaxoSmithKline 1,793.00 27.00 1.53% 26.32%
Hologic 70.35 0.57 0.82% 5.44%
Integra LifeSciences 55.85 1.39 2.55% -18.16%
Intuitive Surgical 202.68 0.60 0.30% -77.96%
J&J 176.99 0.05 0.03% 7.44%
Eli Lilly 323.00 5.38 1.69% 40.73%
Medtronic 90.42 1.22 1.37% -27.16%
Merit Medical Systems 54.58 0.81 1.51% -15.59%
Merck & Co 92.51 0.62 0.67% 18.95%
Novartis 81.19 0.05 0.06% -3.71%
NuVasive 49.98 0.36 0.73% -26.26%
Pfizer 50.94 0.28 0.55% 30.08%
Insulet 221.94 -4.27 -1.89% -19.15%
Regeneron Pharmaceuticals 597.43 3.20 0.54% 6.96%
Roche Holding 319.65 2.10 0.66% -8.29%
Sanofi 100.88 1.51 1.52% 14.17%
Stryker 199.43 1.63 0.82% -23.22%
Teva Pharmaceutical Industries Ltd 2,753.00 -78.00 -2.76% -15.16%
Tandem Diabetes Care 60.19 -0.15 -0.25% -38.20%
Vertex Pharmaceuticals 280.39 4.18 1.51% 39.06%
Zimmer Biomet Holdings Inc 106.55 0.07 0.07% -33.75%
Zoetis 173.92 3.80 2.23% -6.68%

Indexes Price Day Year
US500 3815 -2.72 -0.07% -11.68%
US30 30982 82.32 0.27% -10.54%

J&J
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.